Khaled Sanbar, MD, PhD, of Johns Hopkins Hospital, Baltimore, MD, highlights the challenges faced in the treatment of glioblastoma and the potential of CAR T-cell therapy in treating this highly malignant brain tumor. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).